PAPER
Tetrahydro-2-pyridinones via aza-Diels–Alder Reactions
2457
6,6-Dimethyl-1-[(4-methylphenyl)sulfonyl]-4-(phenylthio)-
1,2,3,6-tetrahydropyridine (6a)
13C NMR: = 21.4, 30.8, 41.0, 79.3, 126.2, 127.1, 127.3, 127.5,
128.3, 129.1, 129.4, 131.9, 133.5, 137.1, 140.2, 140.3, 143.0, 146.8.
Pale yellow liquid (143 mg, 66%).
FAB-MS (relative intensity) m/z: 498 (M++H, 30), 327 (23), 218
(10), 217 (27), 206 (15), 205 (66), 184 (75), 183 (17), 178 (10), 177
(13), 167 (13), 155 (63), 149 (36), 105 (100), 102 (11), 91 (45), 77
(18).
IR (film): 3070, 2971, 2926, 1475, 1439, 1323, 1157, 1094, 814,
744, 691, 662 cm–1.
1H NMR: = 1.40 (6 H, s), 2.41 (3 H, s), 2.62 (2 H, t, J = 6.0 Hz),
3.12 (2 H, d, J = 6.0 Hz), 5.95 (1 H, s), 7.19–7.28 (7 H, m), 7.73 (2
H, d, J = 8.0 Hz).
FAB-HRMS (m/z): calcd for C30H27NO2S2, 497.1483; found,
498.1556 (M++H).
13C NMR: = 21.4, 30.0, 31.6, 41.0, 72.1, 126.8, 127.1, 128.9,
129.4, 130.6, 132.2, 134.3, 137.0, 142.9, 143.5.
EIMS (relative intensity) m/z: 373 (M+, 2), 358 (5), 265 (14), 264
(74), 205 (13), 203 (12), 184 (26), 178 (16), 177 (13), 155 (74), 110
(18), 109 (27), 108 (13), 92 (15), 91 (100), 77 (13), 65 (39), 59 (15),
43 (27).
6,6-Diallyl-1-[(4-methylphenyl)sulfonyl]-4-(phenylthio)-1,2,3,6-
tetrahydropyridine (6e)
Colorless liquid (169 mg, 91%).
IR (film): 3072, 2976, 2925, 1475, 1438, 1322, 1304, 1157, 1094,
918, 814, 745, 691, 663 cm–1.
1H NMR: = 2.33 (4 H, d, J = 6.3 Hz), 2.41 (3 H, s), 2.60 (2 H, t,
J = 5.9 Hz), 3.12 (2 H, t, J = 5.9 Hz), 5.09-5.18 (4 H, m), 5.73–5.87
(3 H, m), 7.20–7.28 (7 H, m), 7.72 (2 H, d, J = 7.9 Hz).
EI-HRMS (m/z): calcd for C20H23NO2S2, 373.1170; found:
373.1172.
6,6-Dibutyl-1-[(4-methylphenyl)sulfonyl]-4-(phenylthio)-
1,2,3,6-tetrahydropyridine (6b)
13C NMR: = 21.3, 30.3, 41.1, 46.4, 75.8, 119.6, 127.1, 128.9,
129.4, 129.4, 131.2, 132.7, 133.9, 134.0, 137.1, 139.6, 142.9.
Pale yellow solid (166 mg, 60%); mp 93–95 °C.
EI-MS (relative intensity) m/z: 425 (M+, 0.1), 403 (10), 402 (43),
360 (10), 232 (10), 231 (69), 219 (30), 189 (15), 184 (51), 177 (45),
163 (24), 155 (88), 110 (16), 109 (18), 91 (100), 77 (12), 69 (26), 67
(18), 65 (29), 41 (40), 39 (16)
IR (film): 2954, 2931, 2860, 1467, 1439, 1323, 1157, 1094, 813,
744, 691, 662 cm–1.
1H NMR: = 0.89 (6 H, t, J = 6.8 Hz), 1.25–1.41 (8 H, m), 1.53 (4
H, t, J = 7.6 Hz), 2.41 (3 H, s), 2.61 (2 H, t, J = 5.9 Hz), 3.13 (2 H,
t, J = 5.9 Hz), 5.73 (1 H, s), 7.19–7.24 (5 H, m), 7.27 (2 H, d, J = 8.1
Hz), 7.74 (2 H, d, J = 8.1 Hz).
EI-HRMS (m/z): calcd for C24H27NO2S2, 425.1483; found,
425.1470.
1-[(4-Methylphenyl)sulfonyl]-4-(phenylthio)-1,2,3,6-
tetrahydro-pyridine (6f)
13C NMR: = 13.9, 21.3, 22.9, 25.9, 30.3, 41.0, 42.5, 77.4, 126.8,
127.1, 128.9, 129.4, 130.9, 132.8, 134.6, 137.2, 141.4, 142.8.
To a solution of 3a (194 mg, 0.54 mmol) in anhyd THF (5.8 mL) at
r.t. was added LiAlH4 (95%, 13 mg, 0.34 mmol). After stirring for
5 h, saturated NaCl solution was slowly added, and was extracted
with CH2Cl2. The organic solution was dried (Na2SO4) and evapo-
rated. The crude product was purified by silica gel column chroma-
tography using hexane–EtOAc (8:1 2:1) with 5–10% of Et3N as
the eluent.
EIMS (relative intensity) m/z: 457 (M+, 3), 418 (28), 248 (12), 247
(71), 235 (43), 209 (23), 184 (42), 177 (11), 163 (28), 155 (79), 110
(11), 92 (10), 91 (100), 85 (88), 65 (13), 57 (32), 41 (15).
EI-HRMS (m/z): calcd for C26H35NO2S2, 457.2109; found,
457.2104.
6,6-Dibenzyl-1-[(4-methylphenyl)sulfonyl]-4-(phenylthio)-
1,2,3,6-tetrahydropyridine (6c)
Pale yellow solid (100 mg, 68%); mp 116–117 °C.
White solid (42 mg, 23%); mp 91–93 °C.
IR (film): 3055, 2922, 2850, 1596, 1474, 1439, 1339, 1304, 1239,
1165, 1099, 1057, 1023, 945, 815, 745, 719, 692, 651, 595 cm–1.
1H NMR: = 2.29 (2 H, br s), 2.43 (3 H, s), 3.21 (2 H, t, J = 5.6 Hz),
3.67 (2 H, d, J = 3.1 Hz), 5.74 (1 H, t, J = 3.1 Hz), 7.26–7.33 (7 H,
m), 7.66 (2 H, d, J = 8.2 Hz).
13C NMR: = 21.4, 29.7, 43.3, 45.7, 123.5, 127.5, 127.6, 129.1,
129.6, 131.6, 131.8, 132.7, 133.5, 143.6.
EIMS (relative intensity) m/z: 345 (M+, 10), 326 (23), 316 (9), 266
IR (film): 3059, 3027, 2922, 2860, 1598, 1494, 1474, 1453, 1439,
1322, 1304, 1235, 1156, 1119, 1032, 1023, 814, 744, 701, 662, 566,
550 cm–1.
1H NMR: = 1.98 (2 H, t, J = 6.0 Hz), 2.40 (3 H, s), 2.76 (2 H, t,
J = 6.0 Hz), 2.87 (2 H, d, J = 13.5 Hz), 2.94 (2 H, d, J = 13.5 Hz),
5.79 (1 H, s), 6.98-7.00 (2 H, m), 7.17–7.30 (15 H, m), 7.50 (2 H, d,
J = 8.2 Hz).
(13), 251 (8), 237 (16), 236 (100), 217 (22).
13C NMR: = 21.4, 29.5, 40.8, 48.5, 77.6, 126.8, 127.1, 128.1,
128.8 (x2), 129.4, 130.7, 131.6, 133.5, 134.0, 136.2, 136.8, 137.9,
142.8.
EI-HRMS (m/z): calcd for C18H19NO2S2, 345.0857; found,
345.0852.
FAB-MS (relative intensity) m/z: 526 (M++H, 40), 452 (12), 355
(27), 281 (18), 269 (10), 184 (27), 155 (47), 91 (100).
6,6-Dibenzyl-1-[(4-methylphenyl)sulfonyl]-4-(phenylsulfonyl)-
1,2,3,6-tetrahydropyridine (6g)
Pale yellow liquid (89 mg, 33%).
FAB-HRMS (m/z): calcd for C32H31NO2S2, 525.1796; found,
526.1884 (M++H).
IR (film): 3060, 3028, 2922, 1598, 1494, 1446, 1453, 1439, 1324,
1291, 1148, 1121, 1092, 1023, 814, 733, 704, 688, 662, 616, 569,
550 cm–1.
1H NMR: = 2.03 (2 H, t, J = 6.7 Hz), 2.39 (3 H, s), 2.54 (2 H, t,
J = 6.7 Hz), 2.97 (4 H, s), 6.97 (1 H, s), 7.15 (10 H, br s), 7.24 (3 H,
d, J = 8.1 Hz), 7.36–7.44 (2 H, t, J = 7.4 Hz), 7.51 (2 H, d, J = 7.4
Hz), 7.57 (2 H, d, J = 8.1 Hz).
13C NMR: = 21.4, 25.8, 41.8, 47.9, 77.8, 126.8, 126.9, 127.8,
128.2, 129.0, 129.4, 130.4, 133.1, 135.4, 136.9, 138.6, 138.9, 143.0,
145.4.
1-[(4-Methylphenyl)sulfonyl]-6,6-diphenyl-4-(phenylthio)-
1,2,3,6-tetrahydropyridine (6d)
Pale yellow liquid (236 mg, 95%).
IR (film): 3057, 3026, 2924, 2860, 1597, 1582, 1491, 1474, 1446,
1326, 1304, 1158, 1120, 1093, 1022, 1001, 813, 747, 701, 666, 634,
550 cm–1.
1H NMR: = 2.40 (3 H, s), 2.42 (2 H, t, J = 6.2 Hz), 3.06 (2 H, t,
J = 6.2 Hz), 6.52 (1 H, s), 7.22–7.34 (17 H, m), 7.65 (2 H, d, J = 8.0
Hz).
Synthesis 2001, No. 16, 2450–2462 ISSN 0039-7881 © Thieme Stuttgart · New York